More From This Series
More By This Author
 Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium, Volume 292
ISBN: 978-0-470-72325-8
Hardcover
222 pages
December 2008
US $195.00
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability. Other Available Formats: E-Book
|
An online version of this product is available through our subscription-based content service. Visit Wiley Online Library now |
- This book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).
- Brings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.
- The book integrates information from human and animal studies.
- The book considers T1D within the broader context of autoimmune disease.
- The format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.
Buy Both and Save 25%!
 |
+ |  |
Buy Defining Optimal Immunotherapies for Type 1 Diabetes: Novartis Foundation Symposium, Volume 292
(List Price: US $195.00)
with Handbook of Clinical Pediatric Endocrinology, 2nd Edition (List Price = US $79.95) Cannot be combined with any other offers. Learn more. |
Share This
